| ONCOMINE: a cancer microarray database and integrated data-mining platform DR Rhodes, J Yu, K Shanker, N Deshpande, R Varambally, D Ghosh, ... Neoplasia 6 (1), 1-6, 2004 | 3933 | 2004 |
| The polycomb group protein EZH2 is involved in progression of prostate cancer S Varambally, SM Dhanasekaran, M Zhou, TR Barrette, C Kumar-Sinha, ... Nature 419 (6907), 624-629, 2002 | 3358 | 2002 |
| Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression A Sreekumar, LM Poisson, TM Rajendiran, AP Khan, Q Cao, J Yu, ... Nature 457 (7231), 910-914, 2009 | 2577 | 2009 |
| Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles DR Rhodes, S Kalyana-Sundaram, V Mahavisno, R Varambally, J Yu, ... Neoplasia 9 (2), 166-180, 2007 | 2282 | 2007 |
| Delineation of prognostic biomarkers in prostate cancer SM Dhanasekaran, TR Barrette, D Ghosh, R Shah, S Varambally, ... Nature 412 (6849), 822-826, 2001 | 2154 | 2001 |
| EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells CG Kleer, Q Cao, S Varambally, R Shen, I Ota, SA Tomlins, D Ghosh, ... Proceedings of the national academy of sciences 100 (20), 11606-11611, 2003 | 2039 | 2003 |
| Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression DR Rhodes, J Yu, K Shanker, N Deshpande, R Varambally, D Ghosh, ... Proceedings of the National Academy of Sciences 101 (25), 9309-9314, 2004 | 1169 | 2004 |
| Meta‐analysis of the association between a serotonin transporter promoter polymorphism (5‐HTTLPR) and anxiety‐related personality traits S Sen, M Burmeister, D Ghosh American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 127 …, 2004 | 954 | 2004 |
| α-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer MA Rubin, M Zhou, SM Dhanasekaran, S Varambally, TR Barrette, ... Jama 287 (13), 1662-1670, 2002 | 905 | 2002 |
| Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression S Varambally, J Yu, B Laxman, DR Rhodes, R Mehra, SA Tomlins, ... Cancer cell 8 (5), 393-406, 2005 | 904 | 2005 |
| Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer DR Rhodes, TR Barrette, MA Rubin, D Ghosh, AM Chinnaiyan Cancer research 62 (15), 4427-4433, 2002 | 838 | 2002 |
| Autoantibody signatures in prostate cancer X Wang, J Yu, A Sreekumar, S Varambally, R Shen, D Giacherio, R Mehra, ... New England Journal of Medicine 353 (12), 1224-1235, 2005 | 762 | 2005 |
| Androgen-independent prostate cancer is a heterogeneous group of diseases: lessons from a rapid autopsy program RB Shah, R Mehra, AM Chinnaiyan, R Shen, D Ghosh, M Zhou, ... Cancer research 64 (24), 9209-9216, 2004 | 744 | 2004 |
| Probabilistic model of the human protein-protein interaction network DR Rhodes, SA Tomlins, S Varambally, V Mahavisno, T Barrette, ... Nature biotechnology 23 (8), 951-959, 2005 | 544 | 2005 |
| Profiling of cancer cells using protein microarrays: discovery of novel radiation-regulated proteins A Sreekumar, MK Nyati, S Varambally, TR Barrette, D Ghosh, ... Cancer research 61 (20), 7585-7593, 2001 | 466 | 2001 |
| Comprehensive literature review and statistical considerations for microarray meta-analysis GC Tseng, D Ghosh, E Feingold Nucleic acids research 40 (9), 3785-3799, 2012 | 452 | 2012 |
| Semiparametric regression of multidimensional genetic pathway data: least-squares kernel machines and linear mixed models D Liu, X Lin, D Ghosh Biometrics 63 (4), 1079-1088, 2007 | 433 | 2007 |
| A polycomb repression signature in metastatic prostate cancer predicts cancer outcome J Yu, J Yu, DR Rhodes, SA Tomlins, X Cao, G Chen, R Mehra, X Wang, ... Cancer research 67 (22), 10657-10663, 2007 | 412 | 2007 |
| Comprehensive assessment of TMPRSS2 and ETS family gene aberrations in clinically localized prostate cancer R Mehra, SA Tomlins, R Shen, O Nadeem, L Wang, JT Wei, KJ Pienta, ... Modern Pathology 20 (5), 538-544, 2007 | 378 | 2007 |
| Identification of GATA3 as a breast cancer prognostic marker by global gene expression meta-analysis R Mehra, S Varambally, L Ding, R Shen, MS Sabel, D Ghosh, ... Cancer research 65 (24), 11259-11264, 2005 | 376 | 2005 |
Mark A RubinProfessor & Director Department for BioMedical Research, University of BernVerified email at dbmr.unibe.ch
